Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Drug Monitoring and Testing
  5. Drugs of Abuse Testing Systems
  6. 21500136

Medtox™ Diagnostics VERDICT™-II Buprenorphine

Catalog No. 21500136
Change view
Click to view available options
Detectable Analytes:
Buprenorphine
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Detectable Analytes
21-500-136 Buprenorphine
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 21-500-136 Supplier Medtox™ Diagnostics Supplier No. 601682
This item is not returnable. View return policy

Description

The VERDICT™-II cassette devices are a reliable way to screen for drugs of abuse, delivering accurate screening results in minutes.

  • 510(k) cleared
  • Screens for buprenorphine
  • Quality management system conforms with ISO 13485
  • Accurate screening results in minutes
  • Made in the USA

Specifications

CE Marker No
Clia Complexity Moderate Complexity
Detectable Analytes Buprenorphine
Disposable Single-use
For Use With (Application) Drug Panel (Urine)
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.